PDIA3 is well-known as an essential component for MHC Class I peptide loading complex which presents antigen to CD8 + cytotoxic T cells to enable tumor antigen recognition and anti-tumor immune responses, hence it is vital for cancer immunotherapy [62]. The gene discussed is CD8A; the disease is neoplasm.